Shares of Obalon Therapeutics (OBLN) surged 414%, Netflix (NFLX) rose 16.85%, Marathon Patent down about 13% among market movers in Wednesday’s trading session. We have highlighted below some of the reasons for the price movements.
Netflix, Inc. (NFLX)
Netflix shares rose 16.85% after the company reported a better-than-expected Q4 sales results, issued Q1 EPS and sales guidance above estimates, and raised FY21 forecast. The share had previously closed at $501, opened Wednesday’s session at $564.29 to close the day at $586.
Beazer Homes USA (BZH)
Shares of BZH had a good day on the floor for Wednesday, January 20 as shares jumped 16.65% to close at $18.36. It had previously closed Tuesday around $15. Beazer Homes USA Inc is an American construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets.
Aray Inc. (ARAY)
Shares of Accuray Incorporated (ARAY) tasted new height as it moved it 52-week high yesterday, hitting a peak of $5.40. It, however, closed at $5.38 after opening at $4.77 for a move of 13.03%. Accuray Inc is a radiation oncology company that develops, manufactures, sells,, and supports precise, innovative treatment solutions that set the standard of radiation therapy care with the aim of helping patients live better lives.
Marathon Patent Group (MARA)
Marathon Patent shares traded in the lower regions following the stock’s recent surge amid strength in Bitcoin prices, which has lifted crypto-related stocks. According to CoinDesk, the price of bitcoin has fallen 8.5% over the last 24 hours. The share price of MARA dropped about 13% after closing the previous day’s trading at $22.35, opened Wednesday at $21.11 to close at $19.27.
Obalon Therapeutics (OBLN)
Shares of Obalon Therapeutics Inc. OBLN, jumped 414.29% higher on massive volume in afternoon trading Wednesday, after the weight loss technologies company announced an agreement to merge with weight loss solutions company ReShape Lifesciences Inc. It closed Tuesday’s session at $1.61, opened Wednesday around $3 to close at $8.28
